OUR
VISION
Monoclonal antibodies make up an effective and rapidly growing class of drugs. They are also critical research tools and essential for the development of many new diagnostics. Isolere Bio was founded with the vision of simplifying and streamlining the purification of biotherapeutics to improve global access to these important drugs.
We are now expanding the application of this technology to gene delivery vectors like adeno-associated virus (AAV). We are working to develop a low-cost, high throughput, and scalable purification platform.
LOW COST
Our product is made entirely recombinantly in E. coli and has no synthetic scaffold. This eliminates the cost of the solid support and chemical conjugation.
SCALABLE
Our process scales linearly, providing a seamless transition from bench to industry scale production.
EASE OF USE
Our technology requires a simple tangential flow filtration (TFF) setup rather than complex chromatography equipment.
MULTIPLE FORMATS
From high throughput 96-well plates, to all-in-one kits, to bulk reagent, our technology can be tailored to suit your needs.
SPEED
Complete an entire round of purification with TFF in under 30 minutes!
